AMRN Competitors
Amarin Corporation plc
$11.32
-$0.25(-2.16%)
40
Overall
60
Value
9
Tech
52
Quality
Market Cap
$239.11M
Volume
113.66K
52W Range
$11.83 - $20.90
Target Price
$13.00
AMRN competitors: ABBV, TEVA, ALKS, GSK, AZN. Amarin Corporation plc is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
AMRN Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| ABBV AbbVie Inc. | $285.42 | $504.37B | $13.94 | 2.39% | 67 |
| TEVA Teva Pharmaceutical Industries Limited | $41.50 | $48.36B | $1.94 | - | 72 |
| ALKS Alkermes plc | $41.22 | $6.92B | $-0.56 | 2.60% | 49 |
| GSK GSK plc | $49.51 | $97.20B | $4.78 | 3.67% | 37 |
| AZN AstraZeneca PLC | $165.41 | $261.34B | $9.36 | 1.44% | 75 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AMRN | $11.32 | -2.2% | 113.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |